Hemolytic uremic syndrome secondary to the treatment of acute lymphoblastic leukemia.
Kanchi
H
H
Webb
N J
NJ
Eden
O B
OB
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D002675:Child, Preschool; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects*
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine